Literature DB >> 33669011

How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn.

Cinzia Signorini1, Patrizia Pignatti2, Teresa Coccini3.   

Abstract

Inflammatory and immune processes are defensive mechanisms that aim to remove harmful agents. As a response to infections, inflammation and immune response contribute to the pathophysiological mechanisms of diseases. Coronavirus disease 2019 (COVID-19), whose underlying mechanisms remain not fully elucidated, has posed new challenges for the knowledge of pathophysiology. Chiefly, the inflammatory process and immune response appear to be unique features of COVID-19 that result in developing a hyper-inflammatory syndrome, and air pollution, the world's largest health risk factor, may partly explain the behaviour and fate of COVID-19. Understanding the mechanisms involved in the progression of COVID-19 is of fundamental importance in order to avoid the late stage of the disease, associated with a poor prognosis. Here, the role of the inflammatory and immune mediators in COVID-19 pathophysiology is discussed.

Entities:  

Keywords:  COVID-19; SARS-CoV2; cytokine storm; genetic polymorphism; immune response; inflammation; pollution

Year:  2021        PMID: 33669011      PMCID: PMC7996623          DOI: 10.3390/life11030182

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  187 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Hypoxia and inflammation are two sides of the same coin.

Authors:  Karsten Bartels; Almut Grenz; Holger K Eltzschig
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-01       Impact factor: 11.205

3.  Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study.

Authors:  Fang Tang; Yan Quan; Zhong-Tao Xin; Jens Wrammert; Mai-Juan Ma; Hui Lv; Tian-Bao Wang; Hong Yang; Jan H Richardus; Wei Liu; Wu-Chun Cao
Journal:  J Immunol       Date:  2011-05-16       Impact factor: 5.422

Review 4.  14-3-3 modulation of the inflammatory response.

Authors:  Claire C Munier; Christian Ottmann; Matthew W D Perry
Journal:  Pharmacol Res       Date:  2020-10-11       Impact factor: 7.658

5.  In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.

Authors:  Xiao-Jing Zhang; Juan-Juan Qin; Xu Cheng; Lijun Shen; Yan-Ci Zhao; Yufeng Yuan; Fang Lei; Ming-Ming Chen; Huilin Yang; Liangjie Bai; Xiaohui Song; Lijin Lin; Meng Xia; Feng Zhou; Jianghua Zhou; Zhi-Gang She; Lihua Zhu; Xinliang Ma; Qingbo Xu; Ping Ye; Guohua Chen; Liming Liu; Weiming Mao; Youqin Yan; Bing Xiao; Zhigang Lu; Gang Peng; Mingyu Liu; Jun Yang; Luyu Yang; Changjiang Zhang; Haofeng Lu; Xigang Xia; Daihong Wang; Xiaofeng Liao; Xiang Wei; Bing-Hong Zhang; Xin Zhang; Juan Yang; Guang-Nian Zhao; Peng Zhang; Peter P Liu; Rohit Loomba; Yan-Xiao Ji; Jiahong Xia; Yibin Wang; Jingjing Cai; Jiao Guo; Hongliang Li
Journal:  Cell Metab       Date:  2020-06-24       Impact factor: 27.287

6.  Estimates of the Global Burden of Ambient [Formula: see text], Ozone, and [Formula: see text] on Asthma Incidence and Emergency Room Visits.

Authors:  Susan C Anenberg; Daven K Henze; Veronica Tinney; Patrick L Kinney; William Raich; Neal Fann; Chris S Malley; Henry Roman; Lok Lamsal; Bryan Duncan; Randall V Martin; Aaron van Donkelaar; Michael Brauer; Ruth Doherty; Jan Eiof Jonson; Yanko Davila; Kengo Sudo; Johan C I Kuylenstierna
Journal:  Environ Health Perspect       Date:  2018-10       Impact factor: 9.031

Review 7.  Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment.

Authors:  Syed Adeel Hassan; Fahad N Sheikh; Somia Jamal; Jude K Ezeh; Ali Akhtar
Journal:  Cureus       Date:  2020-03-21

8.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

9.  Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.

Authors:  Qing Lei; Yang Li; Hong-Yan Hou; Feng Wang; Zhu-Qing Ouyang; Yandi Zhang; Dan-Yun Lai; Jo-Lewis Banga Ndzouboukou; Zhao-Wei Xu; Bo Zhang; Hong Chen; Jun-Biao Xue; Xiao-Song Lin; Yun-Xiao Zheng; Zong-Jie Yao; Xue-Ning Wang; Cai-Zheng Yu; He-Wei Jiang; Hai-Nan Zhang; Huan Qi; Shu-Juan Guo; Sheng-Hai Huang; Zi-Yong Sun; Sheng-Ce Tao; Xiong-Lin Fan
Journal:  Allergy       Date:  2020-10-26       Impact factor: 14.710

View more
  4 in total

Review 1.  Epigenetics at the Intersection of COVID-19 Risk and Environmental Chemical Exposures.

Authors:  Catherine M Bulka; Adam E Enggasser; Rebecca C Fry
Journal:  Curr Environ Health Rep       Date:  2022-06-01

2.  Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19.

Authors:  Ayca Emsen; Sua Sumer; Baykal Tulek; Hilal Cizmecioglu; Husamettin Vatansev; Mevlut Hakan Goktepe; Fikret Kanat; Yavuz Koksal; Ugur Arslan; Hasibe Artac
Journal:  Scand J Immunol       Date:  2021-10-15       Impact factor: 3.889

Review 3.  Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.

Authors:  Laure-Alix Clerbaux; Maria Cristina Albertini; Núria Amigó; Anna Beronius; Gillina F G Bezemer; Sandra Coecke; Evangelos P Daskalopoulos; Giusy Del Giudice; Dario Greco; Lucia Grenga; Alberto Mantovani; Amalia Muñoz; Elma Omeragic; Nikolaos Parissis; Mauro Petrillo; Laura A Saarimäki; Helena Soares; Kristie Sullivan; Brigitte Landesmann
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

Review 4.  COVID-19 vulnerabilities are intensified by declining human serum albumin levels.

Authors:  Andrew S Johnson; William Winlow
Journal:  Exp Physiol       Date:  2021-08-13       Impact factor: 2.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.